Acute tryptophan depletion. Part I: rationale and methodology.
Level 5 - mechanism / opinion, no new human data
Narrative review and expert methodological summary with no systematic review or primary trial dataset.
PubMed 15996136 · doi:10.1080/j.1440-1614.2005.01627.x
What was done
The authors reviewed the historical development, biological rationale, and experimental application of acute tryptophan depletion (ATD) for studying serotonin (5-HT) function, drawing on literature from neuroimaging, neuroendocrine studies, and their experience across five years with over 50 experimental subjects.
What was found
The abstract reports no numerical data or statistical effect sizes. It states qualitatively that acute tryptophan depletion significantly reduces central 5-HT in humans and that non-serotonergic mechanisms for its effects have not been confirmed.
Why it matters
It outlines the procedural basis and rationale for using acute tryptophan depletion as a tool to interrogate serotonin-related mechanisms in psychiatric research.
Limits
This is a narrative overview rather than a systematic review. The abstract provides no quantitative metrics, confidence intervals, or specific protocols, and the synthesis relies partly on uncontrolled experimental observations.
Cited by
- partial Acute tryptophan depletion via branched-chain amino acids reduces brain serotonin levels to approximately 10%.